Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: October 13, 2015

25 Percent of Americans Ages 65 to 74 Have Disabling Hearing Loss

David M. Rubenstein, a philanthropist and co-CEO of The Carlyle Group, a global alternative asset manager, will donate $15 million to the Department Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine to create a new hearing center focused on restoring functional hearing loss.

Released: October 12, 2015

But researchers urge men at risk to step up rates of HBV vaccination

In a study involving 2,400 men who have sex with men who were also enrolled in the Multicenter AIDS Cohort Study, researchers report that men with HIV who were treated effectively with HIV therapy — defined as no detectable HIV virus in the blood — were the least likely (80 percent less likely) to get infected with HBV over a median follow-up of approximately 9.5 years.

Released: October 12, 2015

Study in young patients confirms value of short-term use; results on long-term use forthcoming

A multicenter study of young patients with bipolar disorder provides what may be the most scientifically rigorous demonstration to date that lithium — a drug used successfully for decades to treat adults with the condition — can also be safe and effective for children suffering from it.

Released: October 12, 2015

Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants.

In what they say was a lucky and unexpected finding, researchers at Johns Hopkins say they’ve discovered that male fruit flies lay down an odorant, or pheromone, that not only attracts females to lay eggs nearby, but also guides males and females searching for food. The discovery, they say, offers clues about how flies, and probably other creatures, navigate complex environments and use odors to guide important behavioral decisions.

Released: October 7, 2015

Findings can lead to gut replacement therapy in people with intestinal deficiencies

Working with gut stem cells from humans and mice, scientists from the Johns Hopkins Children’s Center and the University of Pittsburgh have successfully grown healthy intestine atop a 3-D scaffold made of a substance used in surgical sutures.

Released: October 7, 2015

Scientists find three SNPs linked to Hirschsprung’s disease and say regulatory regions should get more attention

Disease gene hunters usually focus on the regions of the genome known as exons, which form the genetic blueprints of proteins. In recent decades, it’s become clear that the DNA letters located between genes play a critical regulatory role, determining whether proteins get made. But exons retain their starring role in disease research. Now, however, as Sumantra Chatterjee, Ph.D., reports Oct. 7 at the annual meeting of the American Society of Human Genetics in Baltimore, newly found genetic contributors to Hirschsprung’s disease suggest that increased research on noncoding DNA could help complete the map of genetic causes of many complex diseases.

Released: October 7, 2015

Finding could lead to treatment for Kabuki syndrome

Studying mice with a genetic change similar to what is found in Kabuki syndrome, an inherited disease of humans, Johns Hopkins researcher Hans Bjornsson, M.D., Ph.D., reports that his team has used a low-carbohydrate diet and a naturally occurring molecule with the same physical effect to “open up” DNA and improve mental function.

Released: October 6, 2015

Johns Hopkins experts say malnutrition and sleep deprivation should become part of the standard safety checklist across hospitals

A Johns Hopkins surgeon and prominent patient safety researcher is calling on hospitals to reform emergency room, surgical and other medical protocols that sicken up to half of already seriously ill patients — in some cases severely — with preventable and potentially dangerous bouts of food and sleep deprivation.

Released: October 1, 2015

The PPO plan provides Medicare Part C benefits to Medicare-eligible residents in 11 Maryland counties

Johns Hopkins HealthCare announces its entrance in the Medicare Advantage market for the 2016 benefit year. The Medicare Advantage product, Johns Hopkins Advantage MD PPO, is the only Maryland Medicare Advantage plan that offers the full complement of Johns Hopkins providers, plus thousands of other network providers across the state of Marylan

Released: October 1, 2015

The Kavli Foundation and its university partners announced on Oct. 1 the founding of three new neuroscience research institutes, including one at Johns Hopkins. The new Kavli Neuroscience Discovery Institute will bring an interdisciplinary group of researchers together to investigate the workings of the brain.

Released: September 30, 2015

Studies of human tumors in mice could eventually assist in tailoring therapies to individuals

Using pieces of human tumors grafted into mice, a team led by Johns Hopkins Kimmel Cancer Center researchers and their colleagues from the University of Torino has identified new mutations in six genes related to drug resistance and sensitivity in late-stage colorectal cancer.

Released: September 29, 2015

One of many light-sensitive pigments was found to set the retina’s own biological tempo while others set the body’s master clock.

Researchers at Johns Hopkins and the University of Washington report new research that sheds light on how the retina sets its own biological rhythm using a novel light-sensitive pigment, called neuropsin, found in nerve cells at the back of the eye.

Released: September 28, 2015

Johns Hopkins Hospital has received the American College of Cardiology’s NCDR ACTION Registry-GWTG Platinum Performance Achievement Award for 2015. Johns Hopkins is one of only 319 hospitals nationwide to receive the honor.

Released: September 28, 2015

Lisa Cooper, M.D., M.P.H., a professor of medicine at the Johns Hopkins University School of Medicine, and her research team, have been selected by the National Institutes of Health (NIH) to receive a $12.2 million research award, which will be funded by the Patient-Centered Outcomes Research Institute (PCORI) through a partnership with NIH.

Released: September 24, 2015

Six Johns Hopkins business startups will participate in a live pitch competition as part of AOL cofounder, Steve Case’s, upcoming Rise of the Rest Road Trip to Baltimore on September 28. In total, eight start-ups will compete and one entrepreneur will win a $100,000 investment in his or her company.

Released: September 24, 2015

Study suggests new material that restores cells’ metabolism and helps them adhere to the heart may have clinical value in heart attack patients

A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, according to results of a new study.

Released: September 24, 2015

Citing an analysis of more than 26,000 Maryland Medicaid claims, Johns Hopkins researchers report evidence that poor women with recent complications during their pregnancies are using the emergency room (ER) at higher rates after delivery and may not be getting the postpartum care and follow-up they need to prevent further health problems.

Released: September 23, 2015

Taking the first close look at a federal program designed to provide cost-savings incentives in exchange for more efficient health care, a Johns Hopkins study published recently in the American Journal of Managed Care found that, while using those cost-savings as incentives for physicians showed promise, there appears to be no single formula for success.

Released: September 22, 2015

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer cells still have the estrogen receptor proteins that the drug normally targets. Now, Johns Hopkins Kimmel Cancer Center scientists and their colleagues have traced out an intricate molecular pathway in those cells they say may explain, at least in part, how tamoxifen resistance develops.

Released: September 21, 2015

James C. Harris, M.D., a professor of psychiatry and behavioral sciences, the founding director of the Developmental Neuropsychiatry Clinic in the Division of Child and Adolescent Psychiatry at Johns Hopkins, and a former director of the Division of Child and Adolescent Psychiatry, has received the American Psychiatric Association’s 2015 Frank J. Menolascino Award for Psychiatric Services to Persons with Intellectual Development Disorders/Developmental Disabilities.